October 19, 2022
Via: Contract PharmaAyala Pharmaceuticals, Inc., a clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers, and Advaxis, Inc., a biotechnology company developing immunotherapies engineered using Listeria monocytogenes, have entered into a definitive merger agreement. The merger would result […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
September 14, 2023
August 30, 2023
September 20, 2023